Lung Cancer Therapeutic Antibodies: Pipeline, Strategies and Clinical

1
Aarkstore.com Lung Cancer Therapeutic
Antibodies Pipeline, Strategies and Clinical
2
Summary

• This report provides a comprehensive review of 27
  candidate therapeutic antibodies that are being
  evaluated for the treatment of lung cancer
  covering pipeline, disease-targeting strategies
  and clinical findings. These antibodies are
  directed at 17 potential targets. Globally,
  lung cancer is the most common cancer and in 2008
  there were an estimated 1.6 million new cases and
  1.4 million deaths (almost 20 of all cancer
  deaths) caused by this disease. Five-year
  survival rates are also low (15-20) compared to
  other common cancers. In the US, studies have
  shown that lung cancer-care costs (in 2006) were
  the third highest of all cancers, while indirect
  costs (2005) were higher than for any other
  cancer. Patient needs and the high burden of
  lung cancer on society drive the development of
  new therapies. While improvements have been seen
  in diagnosis and treatments (surgery,
  radiotherapy, chemotherapy and targeted drugs),
  new therapies that build on the capabilities of
  existing approaches, are urgently
  requiredToday, developments continue to be made
  in drug treatments for lung cancer in
  chemotherapy, new drug combinations, and targeted
  molecules. In particular, advances are being seen
  in the field of immunotherapy in the development
  of new therapeutic antibodies and therapeutic
  vaccines.

3
Table of Contents

• Summary1 Lung Cancer1.1 Statistics1.2
  Diagnosis1.3 Lung Cancer Staging1.4 Treatment
  of Lung Cancer1.5 Survival Rates1.6 Cost of
  Lung Cancer1.7 New Developments1.8 This
  ReportReferencesChapter 2 Approved and
  Late-Stage Therapeutic AntibodiesSummary2.1
  Introduction2.2 Overview2.3 (One antibody,
  Approved)2.4 2.6 (Three antibodies, Phase
  3)References

4
More Related Reports

•   VEGF Inhibition Therapy-Indicating and
  Prognostic Biomarkers, 2011
•   Biomarkers in Alzheimers Disease, 2011
•   Alzheimers Disease Autoantibodies, Vaccines
  and Therapeutic Antibodies Pipeline, 2011
•   Prostate Cancer Vaccines and Therapeutic
  Antibodies Pipeline, 2011
•   Breast Cancer Vaccines and Therapeutic
  Antibodies Pipeline, 2011
•   Alzheimers Disease Biomarkers in Cerebrospinal
  Fluid and Blood, 2011
•   Image-Based Biomarkers in Alzheimers Disease,
  2011
•   Lung Cancer Vaccines and Therapeutic
  Antibodies Pipeline, Strategies and Clinical

5
For More details

• http//www.aarkstore.com/reports/Lung-Cancer-Thera
  peutic-Antibodies-Pipeline-Strategies-and-Clinical
  -157142.html
• Vina
• Aarkstore.com
• Contact Marketing team
• Mob.No.918149852585
• Email enquiry_at_aarkstore.com
• URL http//www.aarkstore.com/
• XML http//www.aarkstore.com/feeds/Biopharmrepor
  ts.xml